Table 4 Characteristics of lung cancer in patients with IPF or non-IPF ILD compared to Pennsylvania state data
Variables | Lung cancer with IPF | Lung cancer with non-IPF ILD | Lung cancer in general population in Pennsylvania | p-value (column 1 vs. 3) | |||
|---|---|---|---|---|---|---|---|
N | Results | N | Results | N | Results | ||
Laterality | 31 | 16 | 100,949 | 0.4 | |||
Left | 14 (45%) | 7 (44%) | 41,745 (41%) | ||||
Right | 16 (52%) | 7 (44%) | 57,566 (57%) | ||||
Bilateral | 1 (3%) | 2 (12%) | 1638 (2%) | ||||
Primary site | 27 | 13 | 85,087 | < 0.001 | |||
Upper lobe | 8 (27%) | 6 (46%) | 53,288 (63%) | ||||
Lower lobe | 17 (63%) | 6 (46%) | 30,422 (36%) | ||||
Others | 2 (7%) | 1 (8%) | 1377 (2%) | ||||
Histology | 27 | 16 | 104,954 | 0.07 | |||
SCC | 11 (41%) | 3 (19%) | 30,596 (29%) | ||||
Adenocarcinoma | 7 (26%) | 10 (63%) | 49,217 (47%) | ||||
Other | 9 (33%) | 3 (19%) | 25,141 (24%) | ||||
Stage | 29 | 16 | 83,994 | 0.6 | |||
I | 9 (31%) | 4 (25%) | 19,000 (23%) | ||||
II | 2 (7%) | 1 (6%) | 4312 (5%) | ||||
III | 7 (24%) | 6 (38%) | 21,730 (26%) | ||||
IV | 11 (38%) | 5 (31%) | 38,952 (46%) | ||||